Longitudinal kidney injury biomarker trajectories in children with obstructive uropathy

Daryl J McLeod1,2, Yuri V Sebastião3, Christina B Ching4,5

  • 1Section of Urology, Nationwide Children's Hospital, Columbus, OH, 43205, USA. Daryl.mcleod@nationwidechildrens.org.

Insights

In children with obstructive uropathy (OU), plasma neutrophil gelatinase-associated lipocalin (pNGAL) and urine liver-type fatty acid-binding protein (uL-FABP) levels increased over time, indicating potential for risk stratification in pediatric kidney disease.

Area of Science:

  • Pediatric Nephrology
  • Biomarker Discovery
  • Urology

Background:

  • Congenital obstructive uropathy (OU) is a primary cause of kidney failure in children.
  • Renal tubular injury from stretch and ischemia is a key mechanism in OU.
  • Tubular injury biomarkers may enhance risk assessment for OU patients.

Purpose of the Study:

  • To investigate the utility of urinary and plasma biomarkers in stratifying risk for pediatric obstructive uropathy.
  • To compare levels of neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18), and liver-type fatty acid-binding protein (L-FABP) in children with and without kidney replacement therapy (KRT).

Main Methods:

  • Patients from the CKiD study with OU were categorized into cases (receiving KRT) and controls (KRT-free).
  • Urine and plasma NGAL, IL-18, and L-FABP levels were measured at baseline and annually.
  • Urine biomarker values were normalized to urine creatinine.

Main Results:

  • No significant differences in biomarkers were observed at enrollment between cases and controls.
  • Plasma NGAL and urine L-FABP/creatinine levels significantly increased annually in cases but remained stable in controls.
  • These findings persisted even after adjusting for baseline glomerular filtration rate (GFR).

Conclusions:

  • Plasma NGAL and urine L-FABP levels rise in the 5 years preceding KRT in children with OU, independent of baseline GFR.
  • These biomarkers show promise for predicting outcomes in pediatric obstructive uropathy.
  • Further research is needed to establish optimal cutoff values and compare their efficacy against existing clinical predictors.
Abstract

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
652
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
205
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
720
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
409
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
463
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
304